- Home
- UPXI vs TNON Comparison
UPXI vs TNON Comparison
Compare UPXI & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPXI
- TNON
- Stock Information
- Founded
- UPXI 2018
- TNON 2012
- Country
- UPXI United States
- TNON United States
- Employees
- UPXI N/A
- TNON N/A
- Industry
- UPXI Medicinal Chemicals and Botanical Products
- TNON Medical Specialities
- Sector
- UPXI Health Care
- TNON Health Care
- Exchange
- UPXI Nasdaq
- TNON Nasdaq
- Market Cap
- UPXI 4.6M
- TNON 4.8M
- IPO Year
- UPXI 2021
- TNON 2022
- Fundamental
- Price
- UPXI $2.92
- TNON $1.39
- Analyst Decision
- UPXI Hold
- TNON Strong Buy
- Analyst Count
- UPXI 1
- TNON 2
- Target Price
- UPXI $25.00
- TNON $16.00
- AVG Volume (30 Days)
- UPXI 71.1K
- TNON 95.9K
- Earning Date
- UPXI 02-14-2025
- TNON 03-11-2025
- Dividend Yield
- UPXI N/A
- TNON N/A
- EPS Growth
- UPXI N/A
- TNON N/A
- EPS
- UPXI N/A
- TNON N/A
- Revenue
- UPXI $18,625,089.00
- TNON $3,315,000.00
- Revenue This Year
- UPXI $299.03
- TNON $29.03
- Revenue Next Year
- UPXI N/A
- TNON $100.29
- P/E Ratio
- UPXI N/A
- TNON N/A
- Revenue Growth
- UPXI 4.75
- TNON 38.30
- 52 Week Low
- UPXI $2.17
- TNON $1.35
- 52 Week High
- UPXI $15.91
- TNON $15.79
- Technical
- Relative Strength Index (RSI)
- UPXI 34.56
- TNON 32.21
- Support Level
- UPXI $3.35
- TNON $1.35
- Resistance Level
- UPXI $4.50
- TNON $1.59
- Average True Range (ATR)
- UPXI 0.36
- TNON 0.11
- MACD
- UPXI -0.06
- TNON 0.01
- Stochastic Oscillator
- UPXI 5.39
- TNON 14.81
About UPXI Upexi Inc.
Upexi Inc specializes in the development, manufacturing, and distribution of consumer products. It reaches consumers through its direct-to-consumer network, wholesale partnerships, and prominent third-party platforms like Amazon.
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants, and 3) SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.